Annual Net Income
-$208.38 M
-$59.54 M-40.01%
December 31, 2023
Summary
- As of February 7, 2025, AUTL annual net profit is -$208.38 million, with the most recent change of -$59.54 million (-40.01%) on December 31, 2023.
- During the last 3 years, AUTL annual net income has fallen by -$66.29 million (-46.65%).
- AUTL annual net income is now -1560.42% below its all-time high of -$12.55 million, reached on September 30, 2016.
Performance
AUTL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$82.09 M
-$23.82 M-40.88%
September 30, 2024
Summary
- As of February 7, 2025, AUTL quarterly net profit is -$82.09 million, with the most recent change of -$23.82 million (-40.88%) on September 30, 2024.
- Over the past year, AUTL quarterly net income has dropped by -$29.40 million (-55.81%).
- AUTL quarterly net income is now -204.60% below its all-time high of -$26.95 million, reached on December 31, 2022.
Performance
AUTL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$270.23 M
-$36.24 M-15.49%
September 30, 2024
Summary
- As of February 7, 2025, AUTL TTM net profit is -$270.23 million, with the most recent change of -$36.24 million (-15.49%) on September 30, 2024.
- Over the past year, AUTL TTM net income has dropped by -$48.97 million (-22.13%).
- AUTL TTM net income is now -894.25% below its all-time high of -$27.18 million, reached on March 31, 2019.
Performance
AUTL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AUTL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.0% | -55.8% | -22.1% |
| 3 y3 years | -46.6% | -80.2% | -74.3% |
| 5 y5 years | -909.2% | -80.2% | -74.3% |
AUTL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.6% | at low | -204.6% | at low | -90.2% | at low |
| 5 y | 5-year | -68.3% | at low | -204.6% | at low | -118.2% | at low |
| alltime | all time | -1560.4% | at low | -204.6% | at low | -894.3% | at low |
Autolus Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$82.09 M(+40.9%) | -$270.23 M(+15.5%) |
| Jun 2024 | - | -$58.27 M(+10.6%) | -$233.98 M(+5.7%) |
| Mar 2024 | - | -$52.69 M(-31.7%) | -$221.26 M(+6.2%) |
| Dec 2023 | -$208.38 M(+40.0%) | -$77.17 M(+68.3%) | -$208.38 M(+31.8%) |
| Sep 2023 | - | -$45.85 M(+0.7%) | -$158.16 M(+2.0%) |
| Jun 2023 | - | -$45.55 M(+14.4%) | -$155.08 M(+2.3%) |
| Mar 2023 | - | -$39.81 M(+47.7%) | -$151.59 M(+1.8%) |
| Dec 2022 | -$148.84 M(+4.7%) | -$26.95 M(-37.0%) | -$148.84 M(-9.0%) |
| Sep 2022 | - | -$42.77 M(+1.7%) | -$163.55 M(+5.7%) |
| Jun 2022 | - | -$42.06 M(+13.5%) | -$154.78 M(+6.1%) |
| Mar 2022 | - | -$37.06 M(-11.0%) | -$145.89 M(+2.7%) |
| Dec 2021 | -$142.10 M | -$41.67 M(+22.6%) | -$142.10 M(-0.8%) |
| Sep 2021 | - | -$33.99 M(+2.5%) | -$143.29 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$33.17 M(-0.3%) | -$146.62 M(+0.8%) |
| Mar 2021 | - | -$33.27 M(-22.4%) | -$145.49 M(+2.4%) |
| Dec 2020 | -$142.09 M(+14.7%) | -$42.86 M(+14.9%) | -$142.09 M(+1.4%) |
| Sep 2020 | - | -$37.31 M(+16.4%) | -$140.18 M(+7.7%) |
| Jun 2020 | - | -$32.05 M(+7.3%) | -$130.11 M(+2.8%) |
| Mar 2020 | - | -$29.87 M(-27.0%) | -$126.54 M(+2.2%) |
| Dec 2019 | -$123.85 M(+499.8%) | -$40.94 M(+50.3%) | -$123.85 M(+49.4%) |
| Sep 2019 | - | -$27.25 M(-4.3%) | -$82.91 M(+49.0%) |
| Jun 2019 | - | -$28.48 M(+4.8%) | -$55.66 M(+104.8%) |
| Mar 2019 | - | -$27.18 M | -$27.18 M |
| Dec 2018 | -$20.65 M(-53.9%) | - | - |
| Sep 2018 | -$44.75 M(+126.9%) | - | - |
| Sep 2017 | -$19.73 M(+57.2%) | - | - |
| Sep 2016 | -$12.55 M | - | - |
FAQ
- What is Autolus Therapeutics annual net profit?
- What is the all time high annual net income for Autolus Therapeutics?
- What is Autolus Therapeutics annual net income year-on-year change?
- What is Autolus Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly net income year-on-year change?
- What is Autolus Therapeutics TTM net profit?
- What is the all time high TTM net income for Autolus Therapeutics?
- What is Autolus Therapeutics TTM net income year-on-year change?
What is Autolus Therapeutics annual net profit?
The current annual net income of AUTL is -$208.38 M
What is the all time high annual net income for Autolus Therapeutics?
Autolus Therapeutics all-time high annual net profit is -$12.55 M
What is Autolus Therapeutics annual net income year-on-year change?
Over the past year, AUTL annual net profit has changed by -$59.54 M (-40.01%)
What is Autolus Therapeutics quarterly net profit?
The current quarterly net income of AUTL is -$82.09 M
What is the all time high quarterly net income for Autolus Therapeutics?
Autolus Therapeutics all-time high quarterly net profit is -$26.95 M
What is Autolus Therapeutics quarterly net income year-on-year change?
Over the past year, AUTL quarterly net profit has changed by -$29.40 M (-55.81%)
What is Autolus Therapeutics TTM net profit?
The current TTM net income of AUTL is -$270.23 M
What is the all time high TTM net income for Autolus Therapeutics?
Autolus Therapeutics all-time high TTM net profit is -$27.18 M
What is Autolus Therapeutics TTM net income year-on-year change?
Over the past year, AUTL TTM net profit has changed by -$48.97 M (-22.13%)